acetyl coenzyme a has been researched along with Enlarged Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, C; Avantaggiati, ML; Catalina-Rodriguez, O; Cheema, A; Foley, P; Gadre, S; Giaccone, G; Graham, GT; Kallakury, B; Kasprzyk-Pawelec, A; Mosaoa, R; Parasido, E; Tan, M; Yi, C | 1 |
1 other study(ies) available for acetyl coenzyme a and Enlarged Liver
| Article | Year |
|---|---|
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Topics: Acetyl Coenzyme A; Animals; Blood Glucose; Carrier Proteins; Cell Polarity; Citric Acid; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Fasting; Gluconeogenesis; Glucose Intolerance; Hepatomegaly; Humans; Hyperglycemia; Inflammation; Insulin Resistance; Interleukin-6; Lipogenesis; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Phenotype; Time Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2020 |